Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT2B | Q92831 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | MYC | P01106 | 1/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | CTSD | P07339 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27814810 | 0.85 | KAT2B (0.38) | KAT2BALDH1A1ALOX15MCL1TSHR | |
| SCHEMBL14699641 | 0.84 | FOLH1 (0.49) | KAT2BALDH1A1ALOX15FOLH1HDAC8 | |
| SCHEMBL16588078 | 0.83 | CTSD (0.46) | KAT2BALDH1A1MYCHDAC3HDAC1 | |
| SCHEMBL15763694 | 0.83 | KAT2B (0.40) | KAT2BALDH1A1MCL1MYCHDAC3 | |
| Hydrochloric Acid SCHEMBL29790654 | 0.81 | KDM4E (0.40) | KAT2BALDH1A1MCL1HPGDTSHR | |
| SCHEMBL15353860 | 0.79 | ALDH1A1 (0.53) | ALDH1A1ALOX15MYCHPGDHTT | |
| SCHEMBL28312340 | 0.77 | KAT2B (0.47) | KAT2BALDH1A1MCL1MYC | |
| SCHEMBL14009414 | 0.76 | L3MBTL1 (0.49) | ALDH1A1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL26110049 | 0.76 | FOLH1 (0.47) | KAT2BALDH1A1ALOX15MYCFOLH1 | |
| SCHEMBL16208886 | 0.75 | KAT2B (0.39) | KAT2BALOX15MCL1MYCCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114199974-A | Screening method of specific binding target protein based on isomer | 南开大学 | 2022-03-18 | — | — | CN | claimed |
| US-11180523-B2 | Design, synthesis and use of synthetic nucleotides comprising charge mass tags | QUANTUMDX GROUP LIMITED (GB) | 2021-11-23 | — | — | US | disclosed |
| US-11180523-B2 | Design, synthesis and use of synthetic nucleotides comprising charge mass tags | QUANTUMDX GROUP LIMITED (GB) | 2021-11-23 | — | — | US | disclosed |
| US-10759824-B2 | Design, synthesis and use of synthetic nucleotides comprising charge mass tags | QUANTUMDX GROUP LIMITED (GB) | 2020-09-01 | — | — | US | disclosed |
| US-10759824-B2 | Design, synthesis and use of synthetic nucleotides comprising charge mass tags | QUANTUMDX GROUP LIMITED (GB) | 2020-09-01 | — | — | US | disclosed |
| US-20190248827-A1 | DESIGN, SYNTHESIS AND USE OF SYNTHETIC NUCLEOTIDES COMPRISING CHARGE MASS TAGS | QUANTUMDX GROUP LIMITED (GB) | 2019-08-15 | — | — | US | disclosed |
| US-20190248827-A1 | DESIGN, SYNTHESIS AND USE OF SYNTHETIC NUCLEOTIDES COMPRISING CHARGE MASS TAGS | QUANTUMDX GROUP LIMITED (GB) | 2019-08-15 | — | — | US | disclosed |
| US-10273261-B2 | Design, synthesis and use of synthetic nucleotides comprising charge mass tags | QUANTUMDX GROUP LIMITED (GB) | 2019-04-30 | — | — | US | disclosed |
| US-10273261-B2 | Design, synthesis and use of synthetic nucleotides comprising charge mass tags | QUANTUMDX GROUP LIMITED (GB) | 2019-04-30 | — | — | US | disclosed |
| US-20190004055-A1 | DESIGN, SYNTHESIS AND USE OF SYNTHETIC NUCLEOTIDES COMPRISING CHARGE MASS TAGS | QUANTUMDX GROUP LIMITED (GB) | 2019-01-03 | — | — | US | disclosed |
| US-8569476-B2 | Method for preparing oligonucleotide | Suzhou Ribo Life Science Co., Ltd. (CN) | 2013-10-29 | — | — | US | disclosed |
| EP-2380896-B1 | A METHOD FOR PREPARING OLIGONUCLEOTIDE | SUZHOU RIBO LIFE SCIENCE CO LTD (CN) | 2013-02-13 | — | — | EP | disclosed |
| EP-2386563-A1 | Novel O-acetylated decasaccharides | Institut Pasteur (FR) | 2011-11-16 | — | — | EP | disclosed |
| EP-2386563-A1 | Novel O-acetylated decasaccharides | Institut Pasteur (FR) | 2011-11-16 | — | — | EP | disclosed |
| EP-2380896-A1 | A METHOD FOR PREPARING OLIGONUCLEOTIDE | Suzhou Ribo Life Science Co., Ltd (CN) | 2011-10-26 | — | — | EP | disclosed |
| US-20110237786-A1 | METHOD FOR PREPARING OLIGONUCLEOTIDE | SUZHOU RIBO LIFE SCIENCE CO., LTD (CN) | 2011-09-29 | — | — | US | disclosed |
| US-20110237786-A1 | METHOD FOR PREPARING OLIGONUCLEOTIDE | SUZHOU RIBO LIFE SCIENCE CO., LTD (CN) | 2011-09-29 | — | — | US | disclosed |
| CN-101684136-A | Method for preparing oligonucleotides | SHENZHEN RIBO BIOTECHNOLOGY CO | 2010-03-31 | — | — | CN | disclosed |
| US-20090233280-A1 | METHOD OF ACQUIRING INFORMATION REGARDING BASE SEQUENCE AND INFORMATION READING DEVICE FOR THE SAME | CANON KABUSHIKI KAISHA (JP) | 2009-09-17 | — | — | US | disclosed |
| WO-2007077952-A1 | METHOD AND DEVICE FOR DETERMINING A NUCLEIC ACID ALLELE OR BASE SEQUENCE | CANON KABUSHIKI KAISHA (JP) | 2007-07-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11180523-B2 | Design, synthesis and use of synthetic nucleotides comprising charge mass tags | POLM, RNGTT, TYMP | KAT2B 1816/4885ALDH1A1 3873/4885ALOX15 4140/4885 |
| US-20190004055-A1 | DESIGN, SYNTHESIS AND USE OF SYNTHETIC NUCLEOTIDES COMPRISING CHARGE MASS TAGS | POLM, RNGTT, TYMP | KAT2B 1816/4885ALDH1A1 3873/4885ALOX15 4140/4885 |
| US-10759824-B2 | Design, synthesis and use of synthetic nucleotides comprising charge mass tags | POLM, RNGTT, TYMP | KAT2B 1816/4885ALDH1A1 3873/4885ALOX15 4140/4885 |
| US-20190248827-A1 | DESIGN, SYNTHESIS AND USE OF SYNTHETIC NUCLEOTIDES COMPRISING CHARGE MASS TAGS | POLM, RNGTT, TYMP | KAT2B 1816/4885ALDH1A1 3873/4885ALOX15 4140/4885 |
| US-10273261-B2 | Design, synthesis and use of synthetic nucleotides comprising charge mass tags | POLM, RNGTT, TYMP | KAT2B 1816/4885ALDH1A1 3873/4885ALOX15 4140/4885 |
| US-20110237786-A1 | METHOD FOR PREPARING OLIGONUCLEOTIDE | POLRMT, POLR2H, RNGTT | KAT2B 2230/4885ALDH1A1 3247/4885ALOX15 1143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.